Target intelligence / Profile preview

Poliovirus, measles virus, mumps virus, and rubella virus (Polio/MMR)

Target
Polio/MMR
Molecular classification
Virus, Pathogen, RNA Virus
01

Overview

Poliovirus, measles virus, mumps virus, and rubella virus are a group of distinct human viral pathogens that are primarily targeted by childhood immunization programs. Poliovirus (Enterovirus C) is a picornavirus that infects the gastrointestinal tract and can spread to the central nervous system, causing paralytic poliomyelitis (CDC, 2024). Measles virus and mumps virus are members of the Paramyxoviridae family; measles causes a severe systemic infection with high fever and respiratory symptoms, while mumps is characterized by painful swelling of the salivary glands (StatPearls, 2023). Rubella virus is the causative agent of German measles, which is typically mild in children but can cause devastating birth defects, known as congenital rubella syndrome, if a woman is infected during pregnancy (WHO, 2023). These viruses are targeted by vaccines such as the MMR (Measles, Mumps, and Rubella) and Polio vaccines, which stimulate the host's immune system to provide long-lasting protection (FDA, 2023). While these vaccines have significantly reduced the global burden of these diseases, challenges remain regarding vaccine hesitancy and the management of outbreaks in under-vaccinated populations.

Other names
Enterovirus CRubeola virusEpidemic parotitis virusGerman measles virusMMR viruses
02

Mechanism of action

Induction of active immunity through the presentation of viral antigens, leading to the production of neutralizing antibodies and memory B and T cells.

03

Biological functions

Viral attachmentViral replicationHost cell entryPathogenesis
04

Disease associations

PoliomyelitisMeaslesMumpsRubellaCongenital rubella syndrome
05

Safety considerations

Vaccine-associated paralytic poliomyelitis (VAPP)Hypersensitivity to vaccine componentsRisk in immunocompromised patientsFebrile seizures
06

Interacting drugs

MMR II vaccine

5 more in the full profile.

07

Biomarkers

Anti-measles IgG/IgMAnti-mumps IgG/IgMAnti-rubella IgG/IgMAnti-poliovirus neutralizing antibodiesViral RNA (RT-PCR)

Beyond the preview

Go deeper on Poliovirus, measles virus, mumps virus, and rubella virus (Polio/MMR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poliovirus, measles virus, mumps virus, and rubella virus (Polio/MMR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call